Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04544462Active Not Recruiting

ANXA5 M2 Haplotyping in IVF Patients and Embryos

Role: lead

NCT06141135Not ApplicableRecruiting

GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial

Role: lead

NCT04628507Not Yet Recruiting

Cell Free Preimplantation Genetic Testing

Role: lead

NCT04167748Not ApplicableRecruiting

Preimplantation Genetic Testing in Women of Advanced Maternal Age

Role: lead

NCT04528498Recruiting

Embryo Health Study

Role: lead

NCT04477863Recruiting

Follow-up With Preimplantation Genetic Testing Patients

Role: lead

All 6 trials loaded